Notice of Closed Meeting, 19267 [2021-07487]
Download as PDF
<![CDATA[
19267
Federal Register / Vol. 86, No. 69 / Tuesday, April 13, 2021 / Notices
SUMMARY OF ANNUAL BURDEN
Type of burden
Obligation
to respond
Reporting .................
Mandatory ................
Information collection description
Interagency Notice of Change in Director
or Executive Officer.
Total Estimated Annual Burden: 214
hours.
General Description of Collection:
Section 32 of the FDIA (12 U.S.C. 1831i)
requires an insured depository
institution or depository institution
holding company under certain
circumstances to notify the appropriate
federal banking agency of the proposed
addition of any individual to the board
of directors or the employment of any
individual as a senior executive officer
of such institution at least 30 days
before such addition or employment
becomes effective. Section 32 of the
FDIA also provides that the FDIC may
disapprove an individual’s service as a
director or senior executive officer of
certain state nonmember banks or state
savings associations if, upon assessing
the individual’s competence,
experience, character, and integrity, it is
determined that the individual’s service
would not be in the best interest of the
depositors of the institution or the
public. The Interagency Notice of
Change in Director or Senior Executive
Officer, with the information contained
in the Interagency Biographical and
Financial Report (described above) as an
attachment, is used by the FDIC to
collect information relevant to assess
the individual’s competence,
experience, character, and integrity.
jbell on DSKJLSW7X2PROD with NOTICES
Request for Comment
Comments are invited on: (a) Whether
the collection of information is
necessary for the proper performance of
the FDIC’s functions, including whether
the information has practical utility; (b)
the accuracy of the estimates of the
burden of the information collection,
including the validity of the
methodology and assumptions used; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. All comments will become
a matter of public record.
Federal Deposit Insurance Corporation.
VerDate Sep<11>2014
18:31 Apr 12, 2021
Jkt 253001
Estimated
number of
respondents
I
107
Estimated
time per
response
(hours)
Estimated
frequency of
responses
On Occasion ............
I
Dated at Washington, DC, on April 7, 2021.
James P. Sheesley,
Assistant Executive Secretary.
[FR Doc. 2021–07498 Filed 4–12–21; 8:45 am]
BILLING CODE 6714–01–P
I
2
Estimated
annual
burden
(hours)
I
214
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2021–07487 Filed 4–12–21; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4163–18–P
Centers for Disease Control and
Prevention
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Notice of Closed Meeting
Centers for Medicare & Medicaid
Services
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Disease, Disability,
and Injury Prevention and Control Special
Emphasis Panel (SEP)—PAR 18–812, NIOSH
Member Conflict Review.
Date: June 24, 2021.
Time: 1:00 p.m.–4:00 p.m., EDT.
Place: Teleconference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact: Michael
Goldcamp, Ph.D., Scientific Review Officer,
Office of Extramural Programs, National
Institute for Occupational Safety and Health,
CDC, 1095 Willowdale Road, Morgantown,
West Virginia 26506, Telephone (304) 285–
5951; MGoldcamp@cdc.gov.
The Director, Strategic Business Initiatives
Unit, Office of the Chief Operating Officer,
Centers for Disease Control and Prevention,
has been delegated the authority to sign
Federal Register notices pertaining to
announcements of meetings and other
committee management activities, for both
the Centers for Disease Control and
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
[Document Identifier: CMS–718–721, CMS–
724, CMS–2088–17 and CMS–1763]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Centers for Medicare &
Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995
(PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, and to allow
a second opportunity for public
comment on the notice. Interested
persons are invited to send comments
regarding the burden estimate or any
other aspect of this collection of
information, including the necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions, the accuracy of
the estimated burden, ways to enhance
the quality, utility, and clarity of the
information to be collected, and the use
of automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
SUMMARY:
Comments on the collection(s) of
information must be received by the
OMB desk officer by May 13, 2021.
DATES:
E:\FR\FM\13APN1.SGM
13APN1
]]>Agencies
[Federal Register Volume 86, Number 69 (Tuesday, April 13, 2021)]
[Notices]
[Page 19267]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-07487]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended, and the Determination of the Director, Strategic
Business Initiatives Unit, Office of the Chief Operating Officer, CDC,
pursuant to Public Law 92-463. The grant applications and the
discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: Disease, Disability, and Injury Prevention
and Control Special Emphasis Panel (SEP)--PAR 18-812, NIOSH Member
Conflict Review.
Date: June 24, 2021.
Time: 1:00 p.m.-4:00 p.m., EDT.
Place: Teleconference.
Agenda: To review and evaluate grant applications.
For Further Information Contact: Michael Goldcamp, Ph.D.,
Scientific Review Officer, Office of Extramural Programs, National
Institute for Occupational Safety and Health, CDC, 1095 Willowdale
Road, Morgantown, West Virginia 26506, Telephone (304) 285-5951;
[email protected].
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-07487 Filed 4-12-21; 8:45 am]
BILLING CODE 4163-18-P
